Related Experiment Videos
[Correlations between the secretory function of pituitary tumors and arterial hypertension in acromegaly]
Endokrynologia Polska
|January 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Endocan: A biomarker for endothelial dysfunction and inflammation, linking maternal obesity and pediatric obesity in a cohort of preterm neonates.
European journal of obstetrics, gynecology, and reproductive biology·2024
The association between AB blood group and neonatal disease.
Journal of neonatal-perinatal medicine·2018
Leptin and ghrelin concentrations and weight loss in Parkinson's disease.
Acta neurologica Scandinavica·2009
Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
International angiology : a journal of the International Union of Angiology·2008
Incidentally discovered adrenal tumors: a lesson from observation of 1,444 patients.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2008
1,161 patients with adrenal incidentalomas: indications for surgery.
Langenbeck's archives of surgery·2007
Macroprolactinoma with an atypical course.
Endokrynologia Polska·2026
Type 5 diabetes mellitus: revisiting malnutrition-related diabetes.
Endokrynologia Polska·2026
Comparative drug survival of biologic classes in psoriasis: a Japanese single-centre cohort study.
European journal of dermatology : EJD·2026
Biologic treatments for palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and network meta-analysis.
European journal of dermatology : EJD·2026
Safety and Efficacy of Doravirine/Islatravir (100 mg/0.25 mg) Once Daily after Islatravir Dose Reduction from 0.75 mg: Week 96 Results from an Open-Label Phase 3 Study in Adults with HIV-1.
Journal of acquired immune deficiency syndromes (1999)·2026
Target engagement and efficacy in disease-modifying trials of synuclein-related disorders.
Brain : a journal of neurology·2026